|
Catalog Number 96181 |
Device Problem
Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
Obstruction/Occlusion (2422)
|
Event Date 05/19/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The event of "vascular occlusion" is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was discarded.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|
|
Event Description
|
Healthcare professional reported injecting a patient with juvéderm® volbella¿ xc.During injection, the patient experienced ¿a vascular occlusion¿ in the upper vermillion border of the lip.The patient was treated with hylenex, aspirin, prednisone 40 mg gel x 3, cephalexin 500 mg bid x 1 week, and ¿heat and massage¿hour.¿ the event is ongoing, noted: ¿slight discoloration/bruising remains.¿.
|
|
Manufacturer Narrative
|
Additional, corrected, and/or changed data: b.5., h.4., h.6.
|
|
Event Description
|
Additional information provided event have resolved approximately a month after treatment.
|
|
Search Alerts/Recalls
|
|
|